Veterinary Medicines

HuveGuard NB

Authorised
  • Eimeria necatrix, strain Mednec 3+8, Live
  • Eimeria brunetti, strain Roybru 3+28, Live
Download as PDF

Product identification

Medicine name:
HuveGuard NB
HuveGuard NB suspensie voor suspensie voor oraal gebruik voor kippen
Active substance:
  • Eimeria necatrix, strain Mednec 3+8, Live
  • Eimeria brunetti, strain Roybru 3+28, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria necatrix, strain Mednec 3+8, Live
    100.00
    unit(s)
    /
    1.00
    Dose
  • Eimeria brunetti, strain Roybru 3+28, Live
    50.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 5000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 5000 doses
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 5000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 115386
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0207/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."